Zealand Pharma A/S (ZLDPF) Financials
ZLDPF Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 3.0 billion | 268.1 million |
| March 31, 2026 | 2.3 billion | 127.8 million |
| Dec. 31, 2025 | 2.6 billion | 255.8 million |
| Sept. 30, 2025 | 2.6 billion | 257.0 million |
ZLDPF Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | 59.8 million | ? |
| March 31, 2026 | -104.7 million | 4.9 million |
| Dec. 31, 2025 | -166.2 million | 4.8 million |
| Sept. 30, 2025 | -11.0 million | 4.8 million |
ZLDPF Net Income
Graph available only for paid members. Upgrade to see it.
| Date | Net Income |
|---|---|
| June 30, 2026 | 596.0 million |
| March 31, 2026 | -60.5 million |
| Dec. 31, 2025 | -59.5 million |
| Sept. 30, 2025 | -63.6 million |
ZLDPF Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 2.2 billion | 47.5 million | 10.7 million |
| March 31, 2026 | 2.2 billion | 47.1 million | 16.4 million |
| Dec. 31, 2025 | 2.4 billion | 60.1 million | 16.1 million |
| Sept. 30, 2025 | 2.5 billion | 46.9 million | 17.0 million |
ZLDPF Shares Outstanding
ZLDPF Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | 2.0 million | 78.5 million | 16.0 million | - |
| March 31, 2026 | 1.5 million | 72.0 million | 16.0 million | 3.4 million |
| Dec. 31, 2025 | 2.6 million | 83.1 million | -20.6 million | -2.4 million |
| Sept. 30, 2025 | 89830 | 7.9 million | 30.0 million | 5.0 million |
ZLDPF Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | 683.3 million | 1.7 million |
| March 31, 2026 | 5.2 million | 1.5 million |
| Dec. 31, 2025 | 10.8 million | 1.3 million |
| Sept. 30, 2025 | 7.8 million | 1.1 million |
ZLDPF
Price: $49.07
52 week price:
Earnings Per Share: 6.04 USD
P/E Ratio: 8.12
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 3.3 billion